QT interval and arrhythmic safety of hydroxychloroquine monotherapy in coronavirus disease 2019

QT interval and arrhythmic safety of hydroxychloroquine monotherapy in coronavirus disease 2019

Background: Observational studies have suggested increased arrhythmic and cardiovascular risk with the combination use of hydroxychloroquine (HCQ) and azithromycin in patients with coronavirus disease 2019 (COVID-19). Objective: The arrhythmic safety profile of HCQ monotherapy, which remains under i...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Arun R. Sridhar, MBBS, MPH, Neal A. Chatterjee, MD, MSc, Basil Saour, MD, Dan Nguyen, MD, Elizabeth A. Starnes, ARNP, Christine Johnston, MD, MPH, Margaret L. Green, MD, MPH, Gregory A. Roth, MD, Jeanne E. Poole, MD, FHRS
Fformat: Erthygl
Iaith:English
Cyhoeddwyd: Elsevier 2020-08-01
Cyfres:Heart Rhythm O2
Pynciau:
Coronavirus
Electrocardiogram
Hydroxychloroquine
QT interval
Ventricular arrhythmia
Mynediad Ar-lein:http://www.sciencedirect.com/science/article/pii/S2666501820300751

Rhyngrwyd

http://www.sciencedirect.com/science/article/pii/S2666501820300751

Eitemau Tebyg